Background/Aims: MicroRNAs (miRNAs) have been reported to be involved in Rheumatoid arthritis (RA) pathogenesis and prognosis. However, little is known about the disease mechanism in RA. Here, we aim to investigate the potential association between miR-338-5p and NFAT5 in RA. Methods: Aberrant expression of miR-338-5p in RA tissues and rheumatoid arthritis fibroblast-like synoviocytes (RAFLSs) compared to the normal were determined by RT-qPCR. Cell viability was determined using the CCK-8 assay, and cell apoptosis was analyzed via Annexin V-FITC/PI double staining and was detected using flow cytometry. The targeted relationship was determined by TargetScan database and dual luciferase reporter gene assay. Results: Upregulation of miR-338-5p facilitated the proliferation, migration, invasion and induced G0/G1 arrest of RAFLSs while miR-338-5p inhibitor functioned oppositely. Nuclear factor of activated T-cells 5 (NFAT5) was confirmed as a downstream target of miR-338-5p which expression was directly suppressed by miR-338-5p. Overexpression of NFAT5 attenuated the proliferation and metastasis of RAFLSs and those changes could be rescued by co-transfection of miR-338-5p. Conclusion: miR-338-5p promotes RAFLS's viability and proliferation, migration by targeting NFAT5, suggesting a novel therapeutic strategy for RA.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that is characterized by propagation of synovial tissue and mainly attacks the joints [1, 2] . RA has complex pathogenesis and unpredictable prognosis [3] . It is widely believed that rheumatoid arthritis fibroblast-like synoviocytes (RAFLSs) play key roles in RA progression [4] [5] [6] . RAFLSs not only passively respond to the regulations from T-cells, B-cells and macrophages, but also actively participate in chronic inflammation of synovial joints which lead to cartilage and bone destruction [7] . An important feature of synovial fibroblasts in RA is the oversecretion of matrix-degrading enzymes and cytokines/chemokines, which then attracts and activated immune cells that stimulate synovial fibroblasts that in turn, resulting in chronic joint inflammation [4, 7] . The inhibition of cytokines/chemokines such as IL-6, IL-29 and TNF-α etc. could reduce RA clinical symptoms [8] , IL-35 might delay RA progression through regulation of the VEGF/Ang2 crosstalk [9] , which explained the critical role of cytokines in RA [10, 11] .
To clarify the pathogenesis mechanism of RA, a recently discovered class of genes transcribing small non-coding RNAs, namely microRNAs, comes into focus, which could be potential serving as new therapeutic strategies for cancers. MicroRNAs are small noncoding RNAs that target specific 3' UTR of mRNAs and thereby degrade targeted mRNAs or hinder the mRNA translation. It was stated that miRNAs have been potential regulators in various diseases [12, 13] . Altered miRNA expression has been reported to be involved in the pathogenesis of RA [14, 15] . For instance, the roles of miR-155 and miR-146a have been thoroughly studied in RA [16] , and the elevated expression of the two miRNAs has been reported by Filkova et al. and Ceribelli et al. [14, 17] . Here, we found miR-338-5p was significantly enriched in RA tissues by microarray analysis. A few studies have discovered the role of miR-338-5p in various disease progressions, such as neural degeneration, an early biomarker of cancers and mitochondrial toxicity [18] [19] [20] [21] [22] . MiR-338-5p was also reported as an immunity-related molecule and RA development was partly attributed to immunity disorder [23] [24] [25] . Hence, it was hypothesized that miR-338-5p might exert a strong influence on aggravation of RA.
By coupling gene expression profiling of synovial tissues and the online database TargetScan Human 7.0, we predicted nuclear factor of activated T-cells 5 (NFAT5) as a potential target gene of miR-338-5p with the binding sequence ATATTGT in its 3'UTR. NFAT5 plays a central role in inducible gene transcription during the immune response and regulates gene expression induced by osmotic stress in mammalian cells [26] . Masuda K et al. revealed that NFAT5 was primarily expressed in synovial tissues in RA rather than those in normal individuals [27] . Kim NH et al. discovered that the xanthine oxidase-NFAT5 pathway regulated macrophage activation and TLR-induced arthritis and the down-regulation of xanthine oxidase-NFAT5 was associated with the less severe arthritis [26] . NFAT5 could indirectly down-regulate miR-140 by up-regulating TGF-β and subsequently activating SMAD3 in osteoarthritis [28] . NFAT5 has been found to be active in carcinoma invasion and RA [29, 30] . In addition, Yoon HJ et al. found that NFAT5 was overexpressed in rheumatoid synovium and that NFAT5 could regulate the synovial propagation and angiogenesis in RA [30] .
In the present study, we found an extremely high expression of miR-338-5p and low expression of NFAT5 in RA tissues and RAFLSs compared to the normal. We also unraveled that miR-338-5p/NFAT5 axis could regulates the biological functions of RAFLSs including cell viability, migration, invasion, cell cycle and apoptosis in vitro, which is helpful to develop meaningful strategies for RA treatment.
Materials and Methods

Tissue samples
The synovial tissues from 60 RA patients were recruited during joint surgery in Jinling Hospital from 2014 to 2016. 17 males and 43 females were included and the mean age was 49 years old. Healthy control synovial tissue samples were obtained from 30 emergent trauma amputation patients consists of 11 males and 19 females; the mean age is 44 years old (Table 1 ). All healthy control specimens were free from RA or osteoarthritis. Written permission was obtained from all participants in the study. The ethics committee's approval was granted by Jinling Hospital. were utilized by Biotechnology Co. Shanghai to assess the gene and miRNA expression patterns respectively. The system contains a large number of probes for 2549 miRNAs and 47000 mRNAs. The intensity data were obtained with the Feature Extraction 10.7 software (Agilent Technologies). All digitized data were analyzed using R language.
RAFLSs and healthy control cells culture
RT-qPCR
Tissue samples were torn into pieces, and then total RNA was extracted using 1ml TRIzol reagent (Thermo Fisher Scientific) for every 30-50mg tissue samples. Separated RNA was then purified and quantified as previously described. For miRNA measurement, reverse transcription was performed using the Taqman MicroRNA Reverse Transcription Kit (Life Technologies, Gaithersburg, USA). QuantiFast SYBR Green PCR kit (Qiagen, Duesseldorf, Germany) was applied to acquire corresponding cDNA for mRNA analysis. Afterwards, real-time PCR was performed using an 7900HT Sequence Detection System (Applied Biosystems, USA). Primer sequences were shown in Table 2 . The fold changes of miRNA and mRNA were calculated using 2 −ΔΔCT method using the level of U6 and GAPDH as the internal control, respectively.
Cell transfection
MiR-338-5p mimic, inhibitor and corresponding control sequences (Negative control 1 1 means miR-338-5p mimic control, and negative control 1 2 means miR-338-5p inhibitor control) were purchased from Sigma-Aldrich, Shanghai. NFAT5 cDNA was synthesized by Genepharma Co., Shanghai, and was inserted into pcDNA3.1 plasmid. RALFs were first plated in a medium without antibiotics. After cells reached 60% confluency, transfections were performed with Lipofectamine 2000 in accordance with manufacturer's protocol. 
Dual luciferase reporter gene assay
The wild type and a mutant 3'UTR sequence of NFAT5 which contained the putative miR-338-5p binding sites were inserted into the pMIR-REPORT Luciferase vectors (Ambion, Austin, USA) to construct pMIR/ NFAT5-wt and pMIR/NFAT5-mut vectors. RAFLSs were collected after co-transfection of pMIR/NFAT5-wt and pMIR/NFAT5-mut with miR-338-5p mimic or miR-338-5p mimic control using Lipofectamine 2000, respectively. Subsequently PLB (Passive Lysis Buffer) was added as well as the plate was gently shaken for 15 minutes at room temperature, and then cell lysates were collected. 50μL LAR II and 10μL cell lysate were added to an EP tube (Eppendorf tube, 0.5 mL), the luciferase intensity RLU1 was obtained. Thereafter 50μL Stop & Glo ® Reagent will be added to the EP tube (Eppendorf tube, 0.5 mL) and the luciferase intensity RLU2 will be obtained. The relative fluorescence intensity ratio will then be presented as the ratio of RLU1/RLU2.
Western Blot
Total proteins were obtained after lysing on ice-cold RIPA buffer (Solaibo, Beijing, China) and then quantified by bicinchoninic acid. Thereafter, electrophoresis on sodium dodecyl sulfate, sodium saltpolyacrylamide gel electrophoresis (SDS-PAGE) gel was performed and then proteins were transferred to the polyvinylidene fluoride (PVDF) membrane and incubated at room temperature for 30~60 minutes. After the 5% low-fat milk solution blocking (1h), primary antibodies were added and incubated overnight at 4℃. Then the membranes were washed with Tris Buffer Solution Tween (TBST) and secondary antibodies were then added and incubated at room temperature for 1h. All antibodies were purchased from Abcam (Cambridge, USA) including ab105886, ab 8227 and ab 97080. Lastly, the Electro-Chemi-Luminescence (ECL) solution was applied and the images were photographed using Bio Doc It (UVP Co, USA) to be analyzed for densitometry by Lab Works 4.5 software.
CCK-8 assay
The Cell Counting Kit-8 assay was performed strictly following corresponding instructions. Briefly, transfected RAFLSs were seeded at 1 × 10 4 / well and cultured for 24, 48 and 72 hours. CCK-8 kit (10 μL, Beyotime, Shanghai, China) was added at each time point and the incubation was sustained for 4 hours before the OD values at 450 nm was determined by a microplate reader (Thermo Fisher Scientific, Waltham, USA). All experiments were done in triplicate and the averages were used for statistical analysis.
Flow cytometry analysis
RAFLSs were collected at 48 hours after transfection and then digested with trypsin. Flow cytometry analysis was carried through Cell Cycle and Apoptosis Analysis Kit (Beyotime, Shanghai, China). Cells were added to 1 mL pre-cooling 70% ethanol, gently blowing mix, 4 ℃ fixed 2 hours. For cell cycle analysis, cells were re-suspended in prepared sample buffer containing 20 μL 5 μg/mL propidium iodide and 50 μL 10 mg/mL RNase A and then incubated in the dark for 10 min at 37 °C. In cell apoptosis analysis, the cells were re-suspended in binding buffer (pH 7.4) including 100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 100 mM NaCl, and 25 mM CaCl2. Lastly, 0.3ml Annexin V-FITC/PI were added to the EP tubes, the cells were incubated for 15min at 37℃. After adding 400 μL binding buffer into each tube, cells in different phases and apoptosis rate were detected using flow cytometry (BD Biosciences, USA).
Transwell assay
Transwell chambers were prepared with or without Matrigel for evaluate the invasive and migratory abilities of transfected RAFLSs respectively. Cells (2.5 × 10 4 ) were seeded in upper chambers and cultured at 5% CO 2 , 37℃ for 48h. The upper chambers were cleaned with sterilized cotton swab to remove the cells attached to the Matrigel on the chambers side. Then the lower membrane was fixed in 4% paraformaldehyde and stained with 0.1% crystal violet. The numbers of stained cells in five random fields were counted lastly.
Statistical analysis
The measurement data were presented as mean ± standard deviation (x̄ ± s). Students' t-test was used to compare normally distributed measurement data between any two groups. And the differences among multiple groups were obtained via one-way ANOVA. All data analysis was performed by GraphPad Prism 6.0, and P < 0.05 was considered statistically significant.
Results
Aberrant expression of miR-338-5p in RA synovial tissues and RAFLSs MicroRNA microchip assay was first performed to identify significant differences in microRNA expression patterns between RA synovial tissues and healthy control. Six miRNAs were found differently expressed in RA tissues compared with the control (P < 0.01, fold change > 2, Fig. 1A and 1B, Table 3 ). Among the six miRNAs, miR-338-5p showed smallest P value and was selected for further research. Then we detected the expression level of miR-338-5p on 60 RA synovial tissues and 30 healthy control samples using RT-qPCR. As shown in Fig. 1C , miR-338-5p was remarkably enriched in RA tissues (P < 0.05). Further, we separated RAFLSs from RA synovial tissues and normal cells from healthy control tissues. RTqPCR further confirmed the high level of miR-338-5p in RAFLSs (P < 0.05, Fig. 1D ). Hence, we predicted that the aberrant expression of miR-338-5p was correlated to the progression of RA.
Regulation of miR-338-5p on biological behaviors in RAFLSs
To investigate the potential role of miR-338-5p on the growth of RAFLSs, we first manipulated the expression of miR-338-5p in RAFLSs by transient transfection. RAFLSs were randomly divided into five groups and transfection was performed in each group using Lipofectamine 2000. Cells were collected at 48 hours after transfection. Accessed by RT-qPCR ( Fig. 2A) , transfection of negative control 1 and negative control 2had little effect on the expression of miR-338-5p compared to the blank control in which group RAFLSs were untreated. And miR-338-5p mimic promoted the expression of miR-338-5p while miR-338-5p inhibitor effectively downregulated its Guo et al.: miR-338-5p Targets NFAT5 and Influences Raflss expression (P < 0.05). Cell proliferation, migration, invasion, cell cycle and apoptosis of transfected RAFLSs was subsequently examined. Detected by CCK-8 assay, overexpressed miR-338-5p increased the cell proliferation which was attenuated in inhibitor group compared to corresponding control group (P < 0.05, Fig. 2B ). However, RASFSs in negative control 1 and negative control 2groups showed similar growth curves with cells in blank group. Measured by Transwell assay, promoted migration and invasion of transfected RAFLSs was also found in mimic group compared with negative control 1 while migratory and invasive cells decreased in inhibitor group compared with negative control 2(P < 0.05, Fig. 2C-2E) . Downregulation of miR-338-5p also induced G0/G1 arrest and increased cell apoptosis rate while overexpression of miR-338-5p functions oppositely (P < 0.05, Fig.  3A-3D) . No significant differences were found among blank control, negative control 1 and negative control 2groups in the four assays. Collective results suggested that miR-338-5p 
promotes the proliferation, migration, invasion and blocked cellular progression from G2/M into G0/G1of RAFLSs.
Identification of NFAT5 as a miR-338-5p target
To find target genes of miR-338-5p, we first investigated gene expression profile in RA tissues and healthy control tissues. Twelve genes were selected and presented in Fig.  4A and 4B (P<0.0001, Fold change > 4, Table 4 ). Then we utilized TargetScan and found 4810 transcripts which contains predicted target sites for miR-338-5p. Venn analysis was then carried out and only NFAT5 remained in the intersectional area of 12 genes and 4810 potential targets. The target relationship was then confirmed by dual luciferase reporting assay. The luciferase reporting constructs (pMIR-REPORT) was generated which contained either wild type or mutant 3'UTR of NFAT5. The mutant 3'UTR of NFAT5 differs from the wild type at 3400-3406 position of NFAT5 which was potential binding sites predicted by TargetScan (Fig. 4C) . Co-transfection was performed in RAFLSs and luciferase activities were detected. As shown in Fig. 4D , the luciferase activity of cells transfected with both pMIR-NFAT5 wt and miR-338-5p mimic significantly decreased compared with cells in pMIR-NFAT5 wt + negative control 1 group (P < 0.05, Fig. 4D ). Meanwhile, cells transfected with pMIR-NFAT5 mut + miR-338-5p mimic and pMIR-NFAT5 mut + negative control 1 showed similar luciferase activity compared with pMIR-NFAT5 wt + negative control 1 group. Above data suggested that NFAT5 3'UTR region could be responsible for miR-338-5p function.
Afterwards, we measured both mRNA expression and protein level of NFAT5 in transfected RAFLSs. Especially, NFAT5 was strongly inhibited by miR-338-5p mimic at both mRNA and protein level while miR-338-5p inhibitor promotes its expression dramatically (P < 0.05, Fig. 4E and 4F ). No significant change was found among blank control, negative control 1 and negative control 2groups. All the evidences supported our hypothesis that miR-338-5p functions on RAFLSs via downregulating NFAT5.
MiR-338-5p promoted biological behaviors via downregulating NFAT5
The low expression of NFAT5 mRNA in RA tissues and RAFLSs compared to relative healthy control was first confirmed using RT-qPCR (P < 0.05, Fig. 5A and 5C ). And Pearson correlation analysis indicated that NFAT5 mRNA expression in RA tissues was negatively correlated with miR-338-5p expression (r=-0.651, P < 0.001, Fig. 5B ). Moreover, the protein level of NFAT5 also decreased in RA tissues and RAFLSs (P < 0.05, Fig. 5D-5F ). The aberrant expression of NFAT5 suggested a compact relationship among miR-338-5p, NFAT5 and RA. Hence, we divided RAFLSs into four groups: Blank control group (Blank) without any treatment, Negative control 1 group (NC) transfected with pcDNA3.1-NFAT5 cDNA, NFAT5 Fig. 6A and 6B ). NFAT5 expression in RAFLSs markedly increased in NFAT5 group compared to blank and NC group while co-transfection with miR-338-5p reverse the amplification in NFAT5 + miR group (P< 0.05). Intriguingly, there is no significant difference among blank, NC and NFAT5 + miR group. Following assay including CCK-8, Transwell and Flow cytometry indicated that overexpression of NFAT5 impaired the cell viability, migratory and invasive abilities of RAFLSs compared to the control (P < 0.05, Fig. 6C-6E ). These negative effects were attenuated by upregulation of miR-338-5p. Moreover, the G1/G0 arrest and enhancive cell apoptosis induced by exogenous NFAT5 could also be attenuated by co-transfection of miR-338-5p (P < 0.05, Fig. 6F-6I ). Taken together, sufficient evidences supported that NFAT5 could suppressed the proliferation, migration, invasion and blocked cellular progression from G2/M into G0/G1 of RAFLSs and miR-338-5p functions conversely on RAFLSs via downregulating RAFLSs.
Discussion
Various studies have identified the role of miRNAs in RA. For instance, Li Z's research suggested that miR-155 overexpressed in RAFLSs decreased MMP-3 levels and inhibited the proliferation and invasion of RAFLSs [31] . Ogando J et al. demonstrated that Notch signaling pathway is inhibited by the overexpression of miR-223 in RA patients [32] . With further efforts, Ogando and his collogues identified miR-223 as a negative regulator of AHR/ARNT pathway by targeting ARNT, which negatively modulates the downstream Notch effectors [32] . Yan C et al. identified mitomycin C induces apoptosis in rheumatoid arthritis fibroblast- Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry like synoviocytes [33] . In our study, the expression level of miR-338-5p in RA synovium was significantly higher than that in normal synovium. Our results suggested that the overexpression of miR-338-5p may promote the proliferation, migration and invasion of RAFLSs. The different expressions of miR-338-5p in rheumatoid arthritis could be due to the differentiated microenvironment of RA synovium.
The putative target of miR-338-5p, NFAT-5, also labeled as TonEBP or OREBP, has been reported to be involved in immune and inflammatory responses regulation as well as tumorigenesis [34] . The expression of NFAT-5 was repressed at both mRNA and protein levels in RA tissues and RAFLSs. Multifarious of priors have studied the influence of NFAT-5 in different diseases. For example, Qin X et al. demonstrated that NFAT5 promotes apoptosis by regulating PARP-1, BAX/BCL2 while inhibits invasion through EMT-related protein claudin-1 and fibronectin [35] ; Hao S et al. indentified that NFAT5 is part of a protective mechanism that limits renal damage induced by IRI (ischemia-reperfusion injury) in experiment [36] , which are similar to our findings. Our Luciferase assay confirmed that miR-338-5p directly targeted NFAT-5. Several reports conveyed the information that NFAT5 could help sustain intracellular homeostasis which is critical for natural cell proliferation [37, 38] . Accumulating evidence suggests that NFAT-5 is attached to cytoskeleton and activate downstream effectors like Cox-2 to facilitate cancer cell metastasis [39] . In addition, NFAT signaling in the tumor microenvironment is likely to have a significant impact on chemokine signaling [40] . In this study, we investigated how NFAT-5 was regulated by miR-338-5p and thereafter influenced RAFLSs in RA occurrence and development. These findings well supported our hypothesis that miR-338-5p may influence the proliferation, migration and the inflammation responses of RAFLSs by targeting NFAT5. We intended to focus on the interplay between NFAT-5 and immune microenvironment and how their interaction regulates the RAFLS activities in the future studies. That would also contribute to understanding of how miR-338-5p influences the inflammatory responses in RA patients. Since sex and age of the RA patients may affect the development of RA, our experiment results have some limitations. Besides, the specific mechanism and functional analysis of miR-338 in cellular pathways as well as the influence of miR-338-5p on RA KEGG pathway still remains to be further studied. The expression of NFAT5 is related to changes in osmotic pressure, the expression of gene NFAT5 may not only connected with miR-338-5p, but with other genes or microenvironment, and needs to be further explored. Relative studies also shown NFAT5 knockdown inhibits hypertonicityinduced chondrogenic marker expression, including AGC1, SOX9, COL2 [41] . The concrete mechanism between NFAT5 and Rheumatoid arthritis may be NFAT5 influences the characteristic of RAFLSs by influencing the downstream gene.
Conclusion
Collectively, our experimental data demonstrated the significance of miR-338-5p activities in RAFLS and further elucidated the interaction between NFAT-5 and miR-338-5p. We illustrated that miR-338-5p could target NFAT5, and promote the RAFLSs proliferation and migration by for the first time. We thereafter identified NFAT5 as a critical player in RAFLS phenotypic modulation, and rendered a complete new perspective of the block of RAFLS migration in RA.
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